GRAZAX®: a sublingual immunotherapy vaccine for Hay fever treatment: from concept to commercialization

Allergen immunotherapy has been used for more than 100 y, but only recently underlying immunological mechanisms have started to be understood. New Allergy vaccines are now considered to be full pharmaceutical products, that should comply with general as well as specific pharmaceutical legal framewor...

Descripción completa

Detalles Bibliográficos
Autores principales: Barber, Domingo, Rico, Pilar, Blanco, Carlos, Fernandez-Rivas, Montserrat, Ibañez, Maria Dolores, Escribese, Maria M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Product Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930101/
https://www.ncbi.nlm.nih.gov/pubmed/31157592
http://dx.doi.org/10.1080/21645515.2019.1622976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930101/
https://www.ncbi.nlm.nih.gov/pubmed/31157592
http://dx.doi.org/10.1080/21645515.2019.1622976

Ejemplares similares